Astressin 05 mg, Each

Details:

Astressin^ 0.5Mg the glu30 to lys33 lactam bridge constrains astressin in an ª-helical conformation which seems to be responsible for its especially high crf antagonist activity. Astressin is 100 times more potent than ª-helical crf (9-41) (h-2040) at inhibiting acth secretion in vitro, and more than 10 times more potent in vivo than any other crf antagonist reported to date. Cas: 170809-51-5 c161h269n49o42 fw: 3563.24 . Synonym: (d-phe12,nle21 38,glu30,lys33)-crf (12-41) (human, rat)